Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • michaelanderson1942 michaelanderson1942 Jun 17, 2013 11:35 AM Flag

    This comment appeared on REGN about Optina and AMPE

    Watch out Very closely for Optina
    The new article, "Is This eye Drug Worth the Hype" mentions Optina as a contender to derail Eylea that of course would send REGN shares tumbling. The author states that some are doubtful of Optina but she doesn't back her comment up. The established scientific medical journal, Retina Today, featured a cover story on how exciting Optina is because it actually repairs the damaged blood vessels in the retina, because it works very fast and because it is a pill and not an injection.

    REGN shareholders are advised to trade some of their shares into AMPE that just began trading on the NYSE today. Optina is positioning to make Eylea obsolete. Less

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMPE
3.77-0.02(-0.53%)May 27 4:02 PMEDT